In FY25, TEXAF delivered solid results amid a complex DRC environment, marking its 100th anniversary with continued resilience. Real estate, the group's core driver, performed strongly with rental income up 13% to €30.8m. This was supported by full-year contributions from Promenade des Artistes and Silikin Village III, a near-100% residential occupancy, and 95% office occupancy. Like-for-like growth was 2.7%. The quarry segment struggled with a 17% revenue decline to €4.2m due to a 26% drop in ...
Aalberts: In-line FY25, but low quality / AMG: 4Q25 beat by 7%; in-line 2026 guidance / Bekaert: In-line 2025, cautious outlook for 2026 to result in c.8% consensus cut / CMB.TECH: A small bit beat but not the full story / Corbion: Dividend sweetener / CTP: Q4 results lighter due to some delays; stronger 2026 outlook / DEME: Strong FY25 numbers and FY26 outlook / Elia Group: Preview FY25 results / SBM Offshore: Another step-up in shareholder return / Syensqo: Substantial miss in 4Q25; FY26 outlo...
FY25 adj EBITDA increased by 27% organically and was close to our and consensus forecasts. FY26 guidance of a c. 100bps adj EBITDA margin improvement to around 17% is no surprise (KBCS 16.7%, CSS 16.9%). We remind that Corbion is conducting a strategic review on PLA which we believe will most likely result in an exit of Corbion, while still remaining the lactic acid supplier to the buyer. Biochemicals will be de-emphasized, which will put the growth focus on food preservation and formulation, al...
Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025. Key highlights annual results 2025: Organic sales growth: +2.2% (Q4: +5.4%) Volume/mix: +3.4% (Q4: +8.8%) Price: -1.2% (Q4: -3.4%) Sales: € 1,267.4 million (Q4: € 310.2 million) Adjusted EBITDA: € 204.3 million (Q...
Ageas: Upgrading net op. result FY26 target to >€1.5bn from €1.35bn in FY25 as M&A starts contributing / CFE: Strong 2H, flips to net cash and outlook better / Deceuninck: FY25 results in line with expectations, Türkiye a tad better / GBL: Exits Umicore fully / Vopak: Five-year SBB programme announced / Wolters Kluwer: 2025 roughly in line, good 2026 outlook
In line proportional EBITDA performance. Proposed cash returns (€1.8 dps) and €100m SBB exceed our expectations. Company upgrades LT OCR targets and LT cash distribution policy announcing €1.7bn returns by 2030. Proportional EBITDA26 guidance of €1150-1200m is in line with our €1187mE but a tad below €1207m CSS. Amidst all geopolitical uncertainties the report underlines the defensiveness & visibility of the business model and this amidst unfavourable FX dynamics. Buy and €50 TP reiterated.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.